BAY 43-9006

sorafenib · Bayer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BAY 43-9006, covering 2009-01-16 to 2023-11-29. Get the full timeline:

Most recent: Clinical Trial Update: MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma [Phase 3]